Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent Cottin

Showing results (361-370 of 468) with videos related to

Pageof 47
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung DiseaseLouis Chauvelot, Delphine Gamondes, Julien Berthiller, et al.
The Lancet. Respiratory Medicine|August 4, 2022
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up studyXavier Jaïs, Philippe Brenot, Hélène Bouvaist, et al.
RMD Open|December 31, 2025
Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counsellingMichele Iudici, Zubeyir Salis, Pascal Cohen, et al.
Thorax|August 12, 2017
Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosisLucile Sesé, Hilario Nunes, Vincent Cottin, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2024
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF studyLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
ERJ Open Research|April 1, 2026
Access to lymphangioleiomyomatosis care across Europe: an ERN-LUNG survey of clinical practice, and the case for a European registry and trial networkDonal O'Malley, Elisabeth Humbert-Dorfmüller, Joan A Barberà, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2016
Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen PatientsMarie Jachiet, Maxime Samson, Vincent Cottin, et al.
Frontiers in Medicine|August 23, 2021
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?Lucile Sesé, Hilario Nunes, Vincent Cottin, et al.
Annals of the Rheumatic Diseases|August 7, 2023
Benralizumab for eosinophilic granulomatosis with polyangiitisAdrien Cottu, Matthieu Groh, Charlene Desaintjean, et al.
Pageof 47

Showing results (361-370 of 468) with videos related to

Sort By:
Pageof 47
Arthritis & Rheumatology (Hoboken, N.J.)|September 6, 2020
Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung DiseaseLouis Chauvelot, Delphine Gamondes, Julien Berthiller, et al.
The Lancet. Respiratory Medicine|August 4, 2022
Balloon pulmonary angioplasty versus riociguat for the treatment of inoperable chronic thromboembolic pulmonary hypertension (RACE): a multicentre, phase 3, open-label, randomised controlled trial and ancillary follow-up studyXavier Jaïs, Philippe Brenot, Hélène Bouvaist, et al.
RMD Open|December 31, 2025
Concordance between presenting features and relapse in granulomatosis with polyangiitis: implications for risk assessment and counsellingMichele Iudici, Zubeyir Salis, Pascal Cohen, et al.
Thorax|August 12, 2017
Role of atmospheric pollution on the natural history of idiopathic pulmonary fibrosisLucile Sesé, Hilario Nunes, Vincent Cottin, et al.
The European Respiratory Journal|July 11, 2015
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune featuresAryeh Fischer, Katerina M Antoniou, Kevin K Brown, et al.
Therapeutic Advances in Respiratory Disease|November 8, 2024
Bexotegrast in people with idiopathic pulmonary fibrosis (IPF): a plain language summary of publication of the INTEGRIS-IPF studyLisa Lancaster, Vincent Cottin, Murali Ramaswamy, et al.
ERJ Open Research|April 1, 2026
Access to lymphangioleiomyomatosis care across Europe: an ERN-LUNG survey of clinical practice, and the case for a European registry and trial networkDonal O'Malley, Elisabeth Humbert-Dorfmüller, Joan A Barberà, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 7, 2016
Anti-IgE Monoclonal Antibody (Omalizumab) in Refractory and Relapsing Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss): Data on Seventeen PatientsMarie Jachiet, Maxime Samson, Vincent Cottin, et al.
Frontiers in Medicine|August 23, 2021
Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?Lucile Sesé, Hilario Nunes, Vincent Cottin, et al.
Annals of the Rheumatic Diseases|August 7, 2023
Benralizumab for eosinophilic granulomatosis with polyangiitisAdrien Cottu, Matthieu Groh, Charlene Desaintjean, et al.
Pageof 47